The word "Fragmin" is a trademarked name for a common medication used to prevent blood clots. It is spelled "frahg-min" with an emphasis on the second syllable. The "F" is pronounced as a voiceless labiodental fricative, the "r" is pronounced as an alveolar approximate, and the "a" is pronounced as a front open vowel. The "g" is pronounced as a voiced velar stop, and the following "m" is a nasal consonant. The final syllable is pronounced as a short "i" sound followed by the alveolar nasal consonant "n".
Fragmin is a trademarked brand name for the generic drug dalteparin sodium. It is a type of medication referred to as a low molecular weight heparin (LMWH), which is derived from heparin, a natural anticoagulant found in the body. Fragmin is primarily used to prevent the formation of blood clots, also known as thrombosis, in individuals at risk of developing deep vein thrombosis (DVT) or pulmonary embolism (PE).
As an anticoagulant, Fragmin works by inhibiting the clotting factors in the blood, preventing them from forming harmful clots. It is commonly administered through subcutaneous injection under the skin, usually in the abdomen. This medication comes in the form of pre-filled syringes or vials containing a clear, colorless solution.
Fragmin is widely prescribed for various medical conditions, including the prevention of blood clots in patients undergoing certain surgeries, such as hip or knee replacements, or medical treatments that carry a high risk of blood clot formation. It is also used in the treatment of acute DVT, unstable angina, and certain heart conditions, including myocardial infarction.
The exact dosage and duration of Fragmin treatment will vary depending on the individual's medical condition, weight, and other factors. It is crucial to follow the prescribed dosage and administration instructions provided by healthcare professionals and to consult with a doctor or pharmacist regarding any concerns or potential drug interactions before using Fragmin.